(Q39423826)

11 September 2017

title

Early infection and spread of a conditionally replicating adenovirus under conditions of plaque formation (English)

1 reference

11 September 2017

1 reference

2

Dominik Wodarz

1 reference

11 September 2017

3

Natalia L Komarova

1 reference

11 September 2017

Andrew Hofacre

1

1 reference

11 September 2017

Hung Fan

series ordinal

4

1 reference

11 September 2017

language of work or name

English

0 references

publication date

20 December 2011

1 reference

11 September 2017

1 reference

11 September 2017

volume

423

1 reference

11 September 2017

issue

1

1 reference

11 September 2017

page(s)

89-96

1 reference

Cancer selective adenoviruses

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

Noninvasive Monitoring of mRFP1- and mCherry-Labeled Oncolytic Adenoviruses in an Orthotopic Breast Cancer Model by Spectral Imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

A comment on amplification and spread of viruses in a growing plaque

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

Time-delayed spread of viruses in growing plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

China approves world's first oncolytic virus therapy for cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

A new technique for the assay of infectivity of human adenovirus 5 DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

p53-dependent cell death/apoptosis is required for a productive adenovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

Image-guided modeling of virus growth and spread

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

Objective determination of the oncolytic potency of conditionally-replicating adenoviruses using mathematical modeling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

ONYX-015: clinical data are encouraging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

ODE models for oncolytic virus dynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

Spatial patterns of protein expression in focal infections of human cytomegalovirus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

Killing tumor cells with viruses--a question of specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

Dynamic monitoring of oncolytic adenovirus in vivo by genetic capsid labeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

Core labeling of adenovirus with EGFP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

Oncolytic viral therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

Gene therapy progress and prospects cancer: oncolytic viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

Noninvasive visualization of adenovirus replication with a fluorescent reporter in the E3 region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

Recent progress in the battle between oncolytic viruses and tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

Oncolytic viruses for the treatment of cancer: current strategies and clinical trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

Viruses as anticancer drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

Oncolytic (replication-competent) adenoviruses as anticancer agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

A fully replication-competent adenovirus vector with enhanced oncolytic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

In vitro dynamic visualization analysis of fluorescently labeled minor capsid protein IX and core protein V by simultaneous detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

Gene therapy for killing p53-negative cancer cells: use of replicating versus nonreplicating agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

Towards predictive computational models of oncolytic virus therapy: basis for experimental validation and model selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

Replication of viruses in a growing plaque: a reaction-diffusion model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

Amplification and spread of viruses in a growing plaque

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

Model-driven approaches for in vitro combination therapy using ONYX-015 replicating oncolytic adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.014

10.1016/J.VIROL.2011.11.014

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference